Invesco Biotechnology & Genome ETF (PBE) Dividend Yield, History & Forecast

Invesco Biotechnology & Genome ETF (PBE) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. The most recent ex-dividend date was March 23, 2026, with payment scheduled for March 27, 2026. market capitalization is approximately $268M.

Frequently Asked Questions about Invesco Biotechnology & Genome ETF (PBE)

When does Invesco Biotechnology & Genome ETF pay distributions?
The most recent ex-dividend date was March 23, 2026. The next scheduled dividend payment date is March 27, 2026.
How many years has Invesco Biotechnology & Genome ETF increased its dividend?
Invesco Biotechnology & Genome ETF (PBE) has increased its dividend for 2 consecutive years.
What does Invesco Biotechnology & Genome ETF invest in?
The Invesco Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Index is comprised of securities of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research,...